Pure Global
NCT06274593

Study of OCT Peripapillary Angiography in Patients With Advanced Glaucoma

Nantes University Hospital·ClinicalTrials.gov·device·Device trialNot yet recruiting
View on ClinicalTrials.gov →
Study focus
Disease/Condition
Glaucoma
Drug/Device/Intervention
OCT
Study type
Observational
Intervention type
device
Sponsor & location
Primary sponsor
Nantes University Hospital
Location
Nantes, France
Timeline & enrollment
Phase
N/A
Start date
Apr 01, 2024
End date
Sep 01, 2027
Enrollment
50 participants
Primary outcome

Compare the progression of vascular density (VD) in advanced glaucoma patients.,Compare the progression of peripapillary retinal nerve fiber (RNFL) thickness) in advanced glaucoma patients.,Compare the progression of visual field in advanced glaucoma patients.

Summary

Glaucoma is a chronic disease of the optic nerve, characterized by progressive loss of nerve
 cells in the retina, leading to progressive loss of peripheral and central vision. There are
 in fact several types of glaucoma, which is the world's second leading cause of blindness
 after cataracts, and the leading cause of irreversible blindness.
 
 To date, to our knowledge, there is no work analyzing the progression of angiographic OCT in
 patients with glaucoma.
 
 The main aim of this study is to compare the 3-year progression rate of 3 examinations in
 advanced glaucoma patients: one functional (visual field) and two anatomical (OCTa and
 OCTrnfl).

ICD-10 classifications
GlaucomaGlaucomaOther glaucomaGlaucoma, unspecifiedGlaucoma in diseases classified elsewhere
Data source
Registry
ClinicalTrials.gov
Trial ID
NCT06274593
Type
Device Trial
About this record

Access comprehensive clinical trial information for NCT06274593 through Pure Global AI's free database. This phase not specified trial is sponsored by Nantes University Hospital and is currently Not yet recruiting. The study focuses on Glaucoma. Target enrollment is 50 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.